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Preparation of (3R,7aS)-7a-(but-3-enyl)-3-phenyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one 13a (n = 1)
Prepared by adaptation of the procedure of Vernon et al. 9 A mixture of (R)-phenyl glycinol (4.115 g, 30 mmol), pyridinium para-toluene sulfonate (1.5 g, 6 mmol) and the crude ketoacid 12a (prepared from 30 mmol succinic anhydride and purified by an acid/base cycle) in 500 ml toluene was heated to reflux in a Dean-Stark apparatus. After 18 h, the reaction mixture was allowed to cool and the resulting precipitate removed by filtration through celite.
After solvent evaporation, the crude product was isolated as a yellow oil and was purified to a colourless oil (2.3502 g, 9.13 mmol, 30%) by column chromatography (50% EtOAc / petroleum ether). R f 0.45 in 50% EtOAc / Petroleum ether; 1 H NMR (400 MHz, CDCl 3 )  ppm 1.63 -1.73 (1H, m, one of 1′-CH 2 ), 1.76 -1. 85 (1 H, m, one of 1′-CH 2 ), 2.12 -2.24 (3H, m, one of 7-CH 2 and both of 2′-CH 2 ), 2.38 (1H, ddd, J=13.5, 9.8, 2.6 Hz, one of 7-CH 2 ), 2.60 (1H, ddd, J=17.3, 10.3, 2.6 Hz, one of 6-CH 2 ), 2.84 (1H, dt, J=17.3, 9.8 Hz, one of 6-CH 2 ), 4.08 (1H, dd, J=8.8, 7.2 Hz, one of 2-CH 2 ), 4.64 (1H, app. t, J=8.5 Hz, one of 2-CH 2 ), 4.93 (1H, ddtd, J=10.1, 1.8, 1.2, 0.5 Hz, Z-H of 4′-CH 2 ), 4.99 (1H, dqd, J=17.1, 1.7, 0.5 Hz, E-H of 4′-CH 2 ), 5.19 (1H, app. t, J=7.7 Hz, 5.75 (1H, m, J=17.0, 10.3, 6.6, 6 .6 Hz, 3′-CH 2 ), 7.21 -7.30 (3 H, m, ArCH), 7.31 -7.37 (2 H, m, ArCH); 13 C NMR (101 MHz, CDCl 3 )
 ppm 28.33 (2′-C), 30.89 (7-C), 33.18 (6-C), 35.50 (1′-C), 57.60 (3-C), 72.88 (2-C), 102.40
(7a-C), 115.06 (5′-C), 125.43 (2″ and 6″-C), 127.40 (4″-C), 128.67 (3″ and 5″-C), 137.29 (3′-C), 140.00 (1″-C), 179.31 (5-C).
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Preparation of (E)-5-((3R,7aS)-5-oxo-3-phenylhexahydropyrrolo[2,1-b]oxazol-7a-yl)pent-2-enal 9a (n = 1)
Hoveyda-Grubbs second generation catalyst (155.9 mg, 248 µmol) was added to a stirring solution of ( 3R,7aS)-7a-(But-3-enyl)-3-phenyl-2,3,7,7a-tetrahydropyrrolo[2,1-b]oxazol-5(6H)-one 13a (1.9 g, 7.38 mmol) and acrolein (2.47 ml, 36.9 mmol) in argon-degassed DCM (120 ml). The mixture was brought to reflux for 6 h, before cooling and transferring to a rotary evaporation flask charged with silica (3 g). The solvent was removed in vacuo and the resulting silica-adsorbed reaction mixture loaded on to a pre-prepared silica column. 
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Preparation of 4-oxonon-8-enoic acid 12b (n = 2) Prepared analogously to 4-oxooct-7-enoic acid 12a, with 5-Bromo-1-pentene (4.3 ml, 36.3 mmol) i n THF (20 ml) added dropwise by cannula over 1 hour to a rapidly stirring suspension of magnesium (2.00 g, 82.2 mmol) in THF (20 ml) in a round-bottom flask equipped with a c ondenser. The solution of G rignard reagent formed was transferred dropwise by cannula to a solution of succinic anhydride (3.63 g, 36.3 mmol) in THF (40 ml), keeping the temperature below -5 °C. Once the addition was complete, the reaction was stirred at 0 °C and left to warm to room temperature overnight. The reaction was quenched with aqueous hydrochloric acid (1 M, 50 ml), and the THF removed by rotary evaporation.
The organic residue was extracted into DCM (2 × 50 ml). The combined organic extracts were washed with NaOH (2 M, 2 × 50 ml). The aqueous layers were re-extracted into DCM (3 × 50 ml) after acidification with concentrated hydrochloric acid. The title compound was isolated crude as a colourless oil, and used directly in the following reaction. 
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Preparation of (3R, 3, 7, Prepared by adaptation of the procedure of Vernon et al. 9 A mixture of (R)-phenyl glycinol (2.87 g, 20.9 mmol), pyridinium para-toluene sulfonate (1.05 g, 4.19 mmol) and the crude keto-acid 12b (prepared from 20.9 mmol succinic anhydride and purified by an acid/base cycle) in 250 ml toluene was heated to reflux in a Dean-Stark apparatus. After 18 h, the reaction mixture was allowed to cool and the resulting precipitate removed by filtration through celite. After solvent evaporation, the crude product was isolated as a yellow oil and was purified to a colourless oil ( 
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Preparation of (E)-6-((3R,7aS)-5-oxo-3-phenylhexahydropyrrolo[2,1-b]oxazol-7a-yl)hex-2-enal 9b (n = 2)
Hoveyda-Grubbs second generation catalyst (105 mg, 211 µmol) was added to a stirring
23 mmol) and acrolein (1.4 ml, 21 mmol) in argon-degassed DCM (180 ml). The mixture was brought to reflux for 6 h, before cooling and transferring to a rotary evaporation flask charged with silica (2 g). The solvent was removed in vacuo and the resulting silica-adsorbed reaction mixture loaded on to a pre-prepared silica column. (0.66 ml, 5.38 mmol) in DCM (2 ml) was added and the reaction stirred for 10 min. SMe 2 (0.40 ml, 5.38 mmol) in DCM (2 ml) was added and the reaction left to warm to room temperature over 18 h. Saturated sodium hydrogen carbonate (25 ml) was added and the mixture sonicated until the brown gum deposit was fully dissolved. DCM (40 ml) was added and the organic layer separated and dried by washing with saturated brine (50 ml 
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Preparation of 6-(hydroxymethyl)-1-(2-hydroxy-1-phenylethyl)-1-azaspiro[4.5]dec-6-en-2-one 14
Prepared according to the procedure of Lawrence et al. 12a Sodium borohydride (17 mg, 450 µmol) was added to a solution of 1-((R)-2-hydroxy-1-phenylethyl)-2-oxo-1-azaspiro[4.5]dec-6-ene-6-carbaldehyde 10b (103.4 mg, 345 µmol) in freshly distilled MeOH (1 ml) at -30 °C.
The reaction mixture was stirred at this temperature for 1 h, before pouring into a biphasic mixture of 1 M HCl (50 ml) and DCM (50 ml) in a separating funnel. Once effervescence had ceased, the aqueous layer was extracted with DCM (2 × 50 ml) and the combined DCM extracts washed with saturated brine (50 ml), then dried over MgSO 4 . Solvent removal in vacuo gave a white foam which was purified by column chromatography (3% → 5% MeOH / DCM) to obtain a white foam (57.4 mg, 192 µmol, 56% yield 
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Preparation of 6-(hydroxymethyl)-1-azaspiro[4.5]dec-6-en-2-one 15
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